Best clinical and research practice in pediatric neurology

Timothy Martland1, J Helen Cross

  • 1Department of Neurology, Royal Manchester Children's Hospital, Hospital Road, Pendlebury, Manchester M27 4HA, UK. timothy.martland@cmmc.nhs.uk

Insights

Children with epilepsy often have broader disabilities impacting development and learning. Addressing these co-occurring impairments is crucial for their well-being and access to services.

Area of Science:

  • Pediatric Neurology
  • Developmental Neuroscience
  • Clinical Psychology

Background:

  • Epilepsy in children frequently co-occurs with broader disabilities, stemming from developmental, genetic, or early acquired abnormalities.
  • Cognitive and language impairments are increasingly recognized, even in idiopathic generalized epilepsies.
  • The interplay of seizures and associated impairments creates significant social and emotional challenges for children and families.

Purpose of the Study:

  • To highlight the multifaceted nature of childhood epilepsy beyond seizures.
  • To emphasize the impact of co-occurring impairments on child development and learning.
  • To underscore the necessity of integrated clinical, educational, and social support services.

Main Methods:

  • Review of current understanding of childhood epilepsy comorbidities.
  • Analysis of the impact of epilepsy and associated impairments on cognitive and social development.
  • Examination of service provision and ongoing research initiatives.

Main Results:

  • Childhood epilepsy is often linked to underlying abnormalities affecting learning and other systems.
  • Even idiopathic generalized epilepsies can present with specific language or cognitive deficits.
  • Effective seizure control and addressing the root cause of impairment are vital for cognitive progress.

Conclusions:

  • Comprehensive assessment and tailored therapies are essential for children with epilepsy and co-occurring conditions.
  • Integrated clinical, educational, and social services are paramount for supporting affected children and their families.
  • Ongoing research is critical for better understanding and managing the diverse impairments associated with childhood epilepsy.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...